|
Myeloid Neoplasia
Citations 131-140 of 176 total displayed.
|
Past content
(since Jan 2009):
|
Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization
- Relja Popovic, Laurie E. Riesbeck, Chinavenmeni S. Velu, Aditya Chaubey, Jiwang Zhang, Nicholas J. Achille, Frank E. Erfurth, Katherine Eaton, Jun Lu, H. Leighton Grimes, Jianjun Chen, Janet D. Rowley, and Nancy J. Zeleznik-Le
Blood 2009; 113: 3314-3322.
[Abstract]
[Full text]
[PDF]
Runx2 induces acute myeloid leukemia in cooperation with Cbfβ-SMMHC in mice
- Ya-Huei Kuo, Sayyed K. Zaidi, Svetlana Gornostaeva, Toshihisa Komori, Gary S. Stein, and Lucio H. Castilla
Blood 2009; 113: 3323-3332.
[Abstract]
[Full text]
[PDF]
ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells
- Monika J. Stankiewicz and John D. Crispino
Blood 2009; 113: 3337-3347.
[Abstract]
[Full text]
[PDF]
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
- Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, Francesco Passamonti, John T. Reilly, Enrica Morra, Alessandro M. Vannucchi, Ruben A. Mesa, Jean-Loup Demory, Giovanni Barosi, Elisa Rumi, and Ayalew Tefferi
Blood 2009; 113: 2895-2901.
[Abstract]
[Full text]
[PDF]
CBFβ is critical for AML1-ETO and TEL-AML1 activity
- Liya Roudaia, Matthew D. Cheney, Ekaterina Manuylova, Wei Chen, Michelle Morrow, Sangho Park, Chung-Tsai Lee, Prabhjot Kaur, Owen Williams, John H. Bushweller, and Nancy A. Speck
Blood 2009; 113: 3070-3079.
[Abstract]
[Full text]
[PDF]
Phorbol ester–induced PKC down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation
- Giuliana Gobbi, Prisco Mirandola, Cecilia Carubbi, Cristina Micheloni, Chiara Malinverno, Paolo Lunghi, Antonio Bonati, and Marco Vitale
Blood 2009; 113: 3080-3087.
[Abstract]
[Full text]
[PDF]
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
- Bas J. Wouters, Bob Löwenberg, Claudia A. J. Erpelinck-Verschueren, Wim L. J. van Putten, Peter J. M. Valk, and Ruud Delwel
Blood 2009; 113: 3088-3091.
[Abstract]
[Full text]
[PDF]
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome
- Sébastien Malinge, Shai Izraeli, and John D. Crispino
Blood 2009; 113: 2619-2628.
[Abstract]
[Full text]
[PDF]
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features
- Maria E. Figueroa, Bas J. Wouters, Lucy Skrabanek, Jacob Glass, Yushan Li, Claudia A. J. Erpelinck-Verschueren, Anton W. Langerak, Bob Löwenberg, Melissa Fazzari, John M. Greally, Peter J. M. Valk, Ari Melnick, and Ruud Delwel
Blood 2009; 113: 2795-2804.
[Abstract]
[Full text]
[PDF]
HOXA9 is required for survival in human MLL-rearranged acute leukemias
- Joerg Faber, Andrei V. Krivtsov, Matthew C. Stubbs, Renee Wright, Tina N. Davis, Marry van den Heuvel-Eibrink, Christian M. Zwaan, Andrew L. Kung, and Scott A. Armstrong
Blood 2009; 113: 2375-2385.
[Abstract]
[Full text]
[PDF]
|
|
